๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Studies in variation associated with the measurement of solid tumors

โœ Scribed by Philip T. Lavin; Gordon Flowerdew

Publisher
John Wiley and Sons
Year
1980
Tongue
English
Weight
448 KB
Volume
46
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Problems associated with homogeneity tes
Problems associated with homogeneity testing in climate variation studies: a case study of temperature in the northern Great Plains, USA
โœ KEISER, DAVID T.; GRIFFITHS, JOHN F. ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 195 KB ๐Ÿ‘ 2 views

Global climate change is a controversial issue facing researchers and climatologists today. In order to obtain the most reliable results when studying climate change, the data being analysed must be as homogeneous as possible. A homogeneous time series is one in which trends and variations are cause

Phase II study of daily oral etoposide i
Phase II study of daily oral etoposide in children with recurrent brain tumors and other solid tumors
โœ Needle, Michael N.; Molloy, Patricia T.; Geyer, J. Russell; Herman-Liu, Alisa; B ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 315 KB ๐Ÿ‘ 2 views

Pre-clinical data and adult experience suggests that topoisomerase targeted anti-cancer agents may be highly schedule dependent, and efficacy may improve with prolonged exposure. To investigate this hypothesis, 28 children with recurrent brain and solid tumors were enrolled in a phase II study of or

A phase I study of gemcitabine and docet
A phase I study of gemcitabine and docetaxel in patients with metastatic solid tumors
โœ David P. Ryan; Thomas J. Lynch; Michael L. Grossbard; Michael V. Seiden; Charles ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 70 KB ๐Ÿ‘ 2 views

A Phase I study was initiated to determine the maximum tolerated dose of weekly gemcitabine combined with monthly, fixed-dose docetaxel. ## METHODS. Patients with metastatic solid tumors were treated with docetaxel, 60 mg/m 2 , on Day 1 every 28 days. Gemcitabine was administered on Days 1, 8, and